{"id":"355","presentation":"COST EFFECTIVENESS ANALYSIS OF MINIMEDTM 670G SYSTEM VERSUS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION, IN INDIVIDUALS WITH TYPE1 DIABETES IN THE UNITED KINGDOM","session":"CLOSED-LOOP SYSTEM AND ALGORITHM","filename":"ATTD 2020 Poster ERP CostEffect SAP 670G UK_final.pptx","speaker":"STEPHANE Roze, France","photo":"","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/attd2020\/355\/jpg\/attd2020postererpcosteffectsap670guk_final\/thumbnails\/0.png","html5":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/attd2020\/355\/html\/attd2020postererpcosteffectsap670guk_final\/data\/","what":"html5","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]